期刊
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY
卷 54, 期 3, 页码 421-430出版社
WILEY
DOI: 10.1111/j.1532-5415.2005.00635.x
关键词
lipids; myocardial infarction; elderly; treatment
资金
- NIA NIH HHS [K08-AG01011, K08 AG020623, K08-AG20623-01, K08 AG001011] Funding Source: Medline
- NIGMS NIH HHS [T32 GM007205, GM07205, T32 GM007205-35] Funding Source: Medline
OBJECTIVES: To characterize the relationship between hydroxymethylglutaryl-CoA reductase inhibitors (statins) and outcomes in older persons with acute myocardial infarction (AMI). DESIGN: Observational study. SETTING: Acute care hospitals in the United States from April 1998 to June 2001. PARTICIPANTS: Medicare patients aged 65 and older with a principal discharge diagnosis of AMI (N = 65,020) who did and did not receive a discharge prescription for statins. MEASUREMENTS: The primary outcome of interest was all-cause mortality at 3 years after discharge. RESULTS: Of 23,013 patients with AMI assessed, 5,513 (24.0%) were receiving a statin at discharge. Nearly 40% of eligible patients (n=8,452) were aged 80 and older, of whom 1,310 (15.5%) were receiving a statin at discharge. In a multivariable model taking into account demographic, clinical, physician and hospital characteristics, and propensity score, discharge statin therapy was associated with significantly lower 3-year mortality (hazard ratio (HR) = 0.89 (95% confidence interval (CI) = 0.83-0.96)). In an analysis stratified by age, discharge statins were associated with lower mortality in patients younger than 80 (HR = 0.84, 95% CI = 0.76-0.92) but not in those aged 80 and older (HR= 0.97, 95% CI = 0.87-1.09). CONCLUSION: Statin therapy is associated with lower mortality in older patients with AMI younger than 80 but not in those aged 80 and older, as a group. This finding questions whether statin efficacy data in younger patients can be broadly applied to the very old and indicates the need for further study of this group.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据